153 related articles for article (PubMed ID: 20551403)
41. Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
Koshy M; Malik R; Weichselbaum RR; Sher DJ
Int J Radiat Oncol Biol Phys; 2015 Feb; 91(2):344-50. PubMed ID: 25636759
[TBL] [Abstract][Full Text] [Related]
42. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
[TBL] [Abstract][Full Text] [Related]
43. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC).
Hof H; Muenter M; Oetzel D; Hoess A; Debus J; Herfarth K
Cancer; 2007 Jul; 110(1):148-55. PubMed ID: 17516437
[TBL] [Abstract][Full Text] [Related]
44. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In reply to Rao et al.
Brown JM; Carlson DJ; Brenner DJ
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):693-4. PubMed ID: 24929172
[No Abstract] [Full Text] [Related]
45. [Stereotactic radiation therapy for non small cell lung cancer].
Uematsu M
Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):256-7. PubMed ID: 11904990
[TBL] [Abstract][Full Text] [Related]
46. Stereotactic body radiation therapy as a derivative of stereotactic radiosurgery: clinically independent but with enduring common themes.
Kavanagh BD
J Clin Oncol; 2014 Sep; 32(26):2827-31. PubMed ID: 25113758
[No Abstract] [Full Text] [Related]
47. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors.
Brown WT; Wu X; Wen BC; Fowler JF; Fayad F; Amendola BE; García S; De La Zerda A; Huang Z; Schwade JG
Comput Aided Surg; 2007 Sep; 12(5):253-61. PubMed ID: 17957532
[TBL] [Abstract][Full Text] [Related]
48. Abscopal [corrected] effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer.
Siva S; Callahan J; MacManus MP; Martin O; Hicks RJ; Ball DL
J Thorac Oncol; 2013 Aug; 8(8):e71-2. PubMed ID: 23857404
[No Abstract] [Full Text] [Related]
49. Dose escalation, not "new biology," can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer.
Brown JM; Brenner DJ; Carlson DJ
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1159-60. PubMed ID: 23517805
[No Abstract] [Full Text] [Related]
50. Pattern of failure following chemoradiation for locally advanced non-small cell lung cancer: potential role for stereotactic body radiotherapy.
Nguyen NP; Bishop M; Borok TJ; Welsh J; Hamilton R; Cohen D; Nguyen LM; Vincent VH
Anticancer Res; 2010 Mar; 30(3):953-61. PubMed ID: 20393019
[TBL] [Abstract][Full Text] [Related]
51. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome.
van der Voort van Zyp NC; Prévost JB; Hoogeman MS; Praag J; van der Holt B; Levendag PC; van Klaveren RJ; Pattynama P; Nuyttens JJ
Radiother Oncol; 2009 Jun; 91(3):296-300. PubMed ID: 19297048
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic body radiation therapy for stage I non-small-cell lung cancer: a historical overview of clinical studies.
Onishi H; Araki T
Jpn J Clin Oncol; 2013 Apr; 43(4):345-50. PubMed ID: 23436937
[TBL] [Abstract][Full Text] [Related]
53. Stereotactic ablative radiation therapy for centrally located recurrences of non-small cell lung cancer: in regard to Chang et al.
Oskan F
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1141-1142. PubMed ID: 25035222
[No Abstract] [Full Text] [Related]
54. Dummy run for a phase II study of stereotactic body radiotherapy of T1-T2 N0M0 medical inoperable non-small cell lung cancer.
Djärv E; Nyman J; Baumann P; Ekberg L; Høyer M; Lax I; Lewensohn R; Levin N; Lund JA; Morhed E; Ericsson SR; Traberg A; Wittgren L; Johansson KA
Acta Oncol; 2006; 45(7):973-7. PubMed ID: 16982566
[TBL] [Abstract][Full Text] [Related]
55. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
Hoppe BS; Huh S; Flampouri S; Nichols RC; Oliver KR; Morris CG; Mendenhall NP; Li Z
Radiother Oncol; 2010 Dec; 97(3):425-30. PubMed ID: 20934768
[TBL] [Abstract][Full Text] [Related]
56. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation.
Hodge W; Tomé WA; Jaradat HA; Orton NP; Khuntia D; Traynor A; Weigel T; Mehta MP
Acta Oncol; 2006; 45(7):890-6. PubMed ID: 16982555
[TBL] [Abstract][Full Text] [Related]
57. Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
Poullis M
J Thorac Oncol; 2016 May; 11(5):e64-e65. PubMed ID: 27131296
[No Abstract] [Full Text] [Related]
58. In Response to Treatment Outcomes in Stage I Lung Cancer: A Comparison of Surgery and Stereotactic Body Radiation Therapy.
Puri V; Robinson CG
J Thorac Oncol; 2016 May; 11(5):e65-e66. PubMed ID: 27131297
[No Abstract] [Full Text] [Related]
59. Dose escalation, not “new biology,” can account for the efficacy of stereotactic body radiation therapy with non-small cell lung cancer. In regard to Brown et al.
Rao SS; Oh JH; Jackson A; Deasy JO
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):692-3. PubMed ID: 24929171
[No Abstract] [Full Text] [Related]
60. Primary non-small cell lung cancer in a transplanted lung treated with stereotactic body radiation therapy. A case study.
Oskan F; Ganswindt U; Belka C; Manapov F
Strahlenther Onkol; 2014 Apr; 190(4):411-5. PubMed ID: 24638242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
